October16 , 2026

    Jeena & Envirotainer Sign MoU to Boost Global Pharma Cold Chain Logistics

    Related

    Visakhapatnam Port Handles 50 Million Tonnes of Cargo in Record 196 Days

    Visakhapatnam Port Authority (VPA) has handled 50.007 million tonnes...

    MV TIGER WEST Berths at Deendayal Port with 71,551 MT of Steam Coal

    MV TIGER WEST has berthed at Deendayal Port Authority...

    Port of Montreal, Adani Group Extend Collaboration to Boost Bilateral Trade

    The Montreal Port Authority and India’s Adani Group have...

    Kochi Port Explores AI-Powered Immigration for Cruise Passengers

    The Indian Ports Association is preparing to float a...

    India–Europe Shipping Corridor Poised for 3 Million Containers a Year

    The proposed India–Middle East–Europe Economic Corridor (IMEC) could eventually...

    Share

    Jeena & Company has entered into a strategic Memorandum of Understanding (MoU) with Envirotainer, a global leader in temperature-controlled air cargo solutions, to strengthen pharmaceutical cold chain logistics worldwide.

    The collaboration brings together Envirotainer’s advanced cold chain technologies and Jeena’s extensive distribution network and local market expertise. The partnership aims to deliver enhanced reliability, innovation, and operational confidence for pharmaceutical shippers.

    Through this alliance, both companies will focus on ensuring seamless handling of temperature-sensitive pharmaceutical shipments across major global pharma hubs. Exporters will benefit from improved access to specialized temperature-controlled equipment and solutions that meet stringent international quality standards.

    The partnership also seeks to safeguard the integrity of critical and life-saving medicines by enhancing shipment visibility, ensuring regulatory compliance, and maintaining high standards of operational excellence across the supply chain.

    With this move, Jeena & Company reinforces its commitment to delivering resilient and future-ready logistics solutions tailored to the evolving needs of the global pharmaceutical industry.